Combination Treatment With All-Trans Retinoic Acid Prevents Cisplatin-Induced Enrichment of CD133+ Tumor-Initiating Cells and Reveals Heterogeneity of Cancer Stem Cell Compartment in Lung Cancer

Journal of Thoracic Oncology - United States

doi 10.1097/jto.0000000000000563